Category Archives: Neglected Diseases

Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control

Source: Health Policy Watch 4th June, 2019   The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this … Continue reading

Posted in Neglected Diseases | Leave a comment

DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises

Source: Health Policy Watch 19th April, 2019 Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available … Continue reading

Posted in Drugs, Neglected Diseases, Vaccines | Leave a comment

DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases

Source: Health Policy Watch 19th April, 2019   Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Atomwise, Inc., a biotech company … Continue reading

Posted in Drugs, Innovation, Neglected Diseases, R&D | Leave a comment

WHO Calls For International Support After Ebola Infections Rise In DRC

Source: Health Policy Watch 15th April, 2019 The World Health Organization called on the international community to ramp up contributions to the US$ 148 million in funding required for the next six months’ Ebola outbreak response in the Democratic Republic … Continue reading

Posted in Ebola, Neglected Diseases, WHO | Leave a comment

Focusing on Neglected Patients

Source: Lasker Foundation | April 25, 2018 Rachel Cohen is the regional executive director of the Drugs for Neglected Diseases initiative (DNDi), a nonprofit drug research and development organization focused on diseases such as leishmaniasis and sleeping sickness. Previously, she worked … Continue reading

Posted in Hepatitis C, HIV/Aids, Neglected Diseases, Uncategorized | Leave a comment

The Zika loopholes

The FDA has a smart-sounding program to drive research for neglected diseases—with two big flaws. Politico; March 25, 2016. By Willo Brock, Rachel Cohen, Jason Cone and Lindsay McKenna. Last week, the Senate voted to add Zika to the list of neglected … Continue reading

Posted in Innovation, Neglected Diseases, Priority Review | Leave a comment

G-Finder Report: Ebola Distracted R&D Funding For Neglected Diseases; Public Funding At Low

IP Watch; December 8, 2015. A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, … Continue reading

Posted in Ebola, Innovation, Neglected Diseases, Public research | Leave a comment